Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
44
ZVRA Quote, Financials, Valuation and Earnings
Last price:
$7.97
Seasonality move
:
-13.78%
Day range:
$8.18 - $8.42
52-week range:
$4.20 - $9.76
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
16.27x
P/B ratio:
11.34x
Volume:
690.2K
Avg. volume:
410.3K
1-year change:
39.17%
Market cap:
$449.7M
Revenue:
$23.6M
EPS (TTM):
-$2.26
Zevra Therapeutics Number of Institutional Trades
Zevra Therapeutics Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$736.3M
(Last 6 Months)
Current Institutional Ownership Percentage
88.6%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$190.8M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Zevra Therapeutics Institutional Ownership
-
What Percentage Of ZVRA Is Owned by Institutions?
88.6% of ZVRA is owned by institutions.
-
How Many Institutions Own ZVRA Shares?
Zevra Therapeutics stock is owned by 219 institutional shareholders at this time.
-
Have Institutions Been Buying ZVRA Stock?
Yes, institutions have bought 50.4M shares of ZVRA in the last quarter.
-
Have Institutions Been Selling ZVRA Stock?
Yes, institutions have sold 15M shares of ZVRA over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
